An official website of the United States government
The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before
sharing sensitive information, make sure you’re on a federal
government site.
The site is secure.
The https:// ensures that you are connecting to the
official website and that any information you provide is encrypted
and transmitted securely.
1 Directorate of Epidemiological Surveillance and Interventions for Infectious Diseases, National Public Health Organization, Athens, Greece. Electronic address: helen-maltezou@ath.forthnet.gr.
2 Department of Microbiology, Andreas Sygros Hospital, National and Kapodistrian University of Athens, Athens, Greece.
3 Mayo Vaccine Research Group, Mayo Clinic and Foundation, 200 First Street, SW Rochester, MN 55905, United States.
1 Directorate of Epidemiological Surveillance and Interventions for Infectious Diseases, National Public Health Organization, Athens, Greece. Electronic address: helen-maltezou@ath.forthnet.gr.
2 Department of Microbiology, Andreas Sygros Hospital, National and Kapodistrian University of Athens, Athens, Greece.
3 Mayo Vaccine Research Group, Mayo Clinic and Foundation, 200 First Street, SW Rochester, MN 55905, United States.
Declaration of Competing Interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: Dr. Poland is the chair of a Safety Evaluation Committee for novel investigational vaccine trials being conducted by Merck Research Laboratories. Dr. Poland offers consultative advice on vaccine development to Merck & Co. Inc., Avianax, Adjuvance, Valneva, Medicago, Sanofi Pasteur, GlaxoSmithKline, Emergent Biosolutions, and Dynavax.Dr. Poland holds patents related to vaccinia and measles peptide vaccines. These activities have been reviewed by the Mayo Clinic Conflict of Interest Review Board and are conducted in compliance with Mayo Clinic Conflict of Interest policies. Dr Maltezou: nothing to declare. Dr. Kalliopi Theodoridou: nothing to declare
Verelst F., Kuylen E., Beutels P. Indications for healthcare surge capacity in European countries facing an exponential increase in coronavirus disease (COVID-19) cases, March 2020. Eurosurveill. 2020;25:2000323.
-
PMC
-
PubMed
Faust J.S., del Rio C. Assessment of deaths from COVID-19 and from seasonal influenza. JAMA Intern Med. 2020 doi: 10.1001/jamainternmed.2020.2306. May 14.
-
DOI
-
PubMed
Flores S., Gavin N., Romney M.L., Tedechi C., Olsen E., Heravian A. COVID-19: New York City pandemic notes from the first 30 days. Am J Emerg Med. 2020;S0735–6757(20):30283–30287.
-
PMC
-
PubMed
Heinzerling A., Stuckey M.J., Scheuer T., Xu K., Perkins K.M., Resseger H. Transmission of COVID-19 to health care personnel during exposures to a hospitalized patient – Solano County, California, February 2020. MMWR Morb Mortal Wkly Rep. 2020;69:472–476.
-
PMC
-
PubMed
